Vaccination Programme
Dail Éireann — 2026-01-27
============================================================

Pádraig O'Sullivan (FF), Cork North-Central

I thank the Minister of State for coming this evening to take this Topical Issue matter.
Over recent months, there has been ongoing debate about the merits of providing enhanced influenza vaccines such as high-dose or adjuvanted formulations for people aged 65 years and older. The Health Information and Quality Authority, HIQA, conducted a health technology assessment, HTA, which found that enhanced vaccines are likely to provide greater protection than standard influenza vaccines in older adults, with the potential to reduce severe illness, hospitalisation and influenza-related mortality in this high-risk group. Despite these findings, the HSE did not proceed with a tender for enhanced influenza vaccines last year, citing cost-effectiveness concerns. However, the scale and severity of the influenza outbreak in recent weeks, characterised by high levels of community transmission, significant pressure on hospitals and a disproportionate impact on older people, raises questions about whether the current approach adequately reflects the true cost of influenza to the health system. Hospital admissions, bed occupancy and delayed discharges during peak flu periods carry substantial financial and operational consequences. Preventing even a modest proportion of these admissions through improved vaccine effectiveness could offset the higher upfront cost of enhanced vaccines.
In addition, vaccine uptake among older adults remains suboptimal in some communities, suggesting that availability alone is not sufficient. Public awareness, confidence and timely access all play critical roles in determining vaccination rates. Clear public messaging, earlier seasonal campaigns and stronger engagement through GPs, pharmacists and community organisations may help to improve uptake, particularly among those at risk of severe outcomes. In light of this year's flu cases and associated hospitalisations, what consideration has been given to funding an enhanced flu vaccination programme for older adults ahead of the next flu season? What measures are being considered to improve public awareness, confidence and uptake of the flu vaccine among older people to maximise the impact of the vaccination programme and reduce preventable illness and hospital pressure?
We are not a million miles off the vaccination target for the age cohort of 65 and older. However, another concern I have is for those aged between two and 17. The HSE has a target that 50% of children in that cohort will be vaccinated, but we are way below that, at below 20%. Will the Minister of State give consideration to improving uptake of the flu vaccine among children?

---

Source: Houses of the Oireachtas. Licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). The Official Report is revised after first publication; the fetch timestamp below identifies the version quoted.

Record URI: https://data.oireachtas.ie/akn/ie/debateRecord/dail/2026-01-27/debate/main
Retrieved: 2026-09-14T01:01:01+00:00
Sitting date: 2026-01-27